Location History:
- Rockville, MD (US) (1998 - 2005)
- Kanagawa, JP (2007 - 2012)
Company Filing History:
12 out of 3,539 
3 out of 1,217 
1 out of 1 Years Active: 1998-2012
Title: Yutaka Kawakami: Innovator in Melanoma Research
Introduction
Yutaka Kawakami is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of melanoma research, holding a total of 16 patents. His work focuses on the development of immunogenic peptides and their applications in diagnostic and therapeutic methods.
Latest Patents
Kawakami's latest patents include innovative approaches to melanoma antigens. One of his notable inventions provides an isolated or purified immunogenic peptide comprising 8-15 contiguous amino acids of gp100. This invention also encompasses related nucleic acids, expression vectors, host cells, and methods of use. Furthermore, he has developed immunogenic peptides derived from gp100 that have been modified to enhance their immunogenicity, along with associated nucleic acids and methods of use.
Career Highlights
Throughout his career, Yutaka Kawakami has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His research has significantly advanced the understanding of melanoma and its treatment options.
Collaborations
Kawakami has collaborated with notable colleagues in the field, including Steven A. Rosenberg and Masahiro Toda. These partnerships have contributed to the success of his research and the development of innovative therapeutic methods.
Conclusion
Yutaka Kawakami's contributions to melanoma research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in diagnostic and therapeutic methods for melanoma.